To evaluate the performance of ultrasound with pattern recognition by experts, Risk of Malignancy Index (RMI) and IOTA ADNEX in the differentiation between benign and malignant adnexal masses. Methods: This is a retrospective diagnostic accuracy study, based on data prospectively collected from patients with adnexal masses (Viewpoint data base), who underwent transvaginal and/or transabdominal examination by experienced examiners in our department between December 2016 and December 2017. The risk of malignancy, defined as invasive or borderline tumours, was determined by pattern recognition and the use of two prediction models: the ADNEX model and the Risk of Malignancy Index (RMI, cut off 200). Histological findings were the clinical reference standard.
OP03.05 Clinical history of low-risk ovarian lesions in postmenopausal women
F. Leone, G. Colletti, A. Crepaldi, S. Cammarata, E. Taricco Obstetrics and Gynecology, DSC L.Sacco, Milan, Italy Objectives: To investigate the ultrasound-based clinical history of incidental low-risk ovarian lesions in postmenopausal women and to propose a proper management. Methods: Women presenting with incidental sonographic diagnosis of ovarian unilocular cysts ≥ 5 cm and ≤ 7 cm, multilocular cysts (<10 locules) ≤ 7 cm, and solid lesions ≤ 5 cm with acoustic shadowing, moving with no tender and colour score 1-2, were prospectively recruited from January 2006 to December 2011, and followed-up until December 2017. All patients were assessed by transvaginal sonography (TVS), according to the IOTA protocol. A proper counselling on a low malignant risk was given. Sonographic follow-up was proposed at 3, 6 and 9 months, then yearly. Surgery was performed in case of changes of lesion's volume (>50%) and/or sonographic parameters, or on patient's request. Demographic, medical, sonographic and pathologic data were recorded.
Results: 125 postmenopausal patients with 134 ovarian masses were enrolled. Median age (IR) was 65 years (58-73). 52 (42%) and 63 (50%) patients had at least one medical disease and one previous abdominal surgery, respectively. Unilocular, multilocular and solid lesions were observed in 55, 61 and 18 cases, respectively. 9 women reported bilateral cysts. Median lesion mean diameter and volume (IR) of unilocular, multilocular ovarian cysts and solid lesions was 48 mm (31-55) and 52 mL (15-87), respectively. All lesions had a mean (±SD) risk of malignancy of 2.7±1% by LR1 and identified as benign by simple rules. In the 88 patients with a follow-up period longer than 12 months (median 66, IR 37-91), surgery was performed in 23 cases, with an overall surgery-free survival rate at 50 months of 83.4%, 90,5%, and 82.2% for patients with unilocular, multilocular and solid lesions, respectively. No malignant lesions were reported in the 48 operated patients. Conclusions: Conservative expectant management should be the standard option for incidental low-risk ovarian lesions in postmenopausal women. Objectives: Ovarian cancer mortality remains high mainly due to late diagnosis. Since 1999, we have performed colour Doppler transvaginal (CDTV) ultrasound to screen for ovarian cancer. The purpose of this paper is to assess the efficiency of CDTV ultrasound to detect ovarian cancer in early stages. Methods: Screening by CDTV ultrasound was annually performed in asymptomatic women with no family history of ovarian cancer. Women with abnormal screenings had repeat tests after four to six weeks. If the finding remitted, CDTV ultrasound follow-up was performed at one year. If the abnormality persisted, the study was completed with tumour markers, CT scan, and laparoscopy. Results: A total of 441.232 CDTV ultrasound screenings performed in 120.627 women were reviewed. Malignant tumours were diagnosed and histologically confirmed in 82 patients. Borderline lesions were detected in 36 of them (45%). The mean age of the patients was 47 years (±12). Fifty-nine (74%) of these tumours were in stage I (including two cases of Fallopian tube carcinoma); four were in stage II; 17 were in stage III; and two lesions detected were metastases. Sixty-five percent of the patients had normal levels of CA 125, measured after the lesions were detected by CDTV ultrasound study. Conclusions: Although consensus about the benefits of transvaginal ultrasound as a screening procedure is not unanimous, our data suggest that tumours in patients screened with CDTV ultrasound are detected at earlier stages. Additional randomised studies are needed to support these findings.
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